Search from over 60,000 research works

Advanced Search

Weight of evidence needed to substantiate a health effect for probiotics and prebiotics: regulatory considerations in Canada, EU, and US

Full text not archived in this repository.
Add to AnyAdd to TwitterAdd to FacebookAdd to LinkedinAdd to PinterestAdd to Email

Sanders, M.E., Tompkins, T., Heimbach, J.T. and Kolida, S. (2005) Weight of evidence needed to substantiate a health effect for probiotics and prebiotics: regulatory considerations in Canada, EU, and US. European Journal of Nutrition, 44 (5). pp. 303-310. ISSN 1436-6207 doi: 10.1007/s00394-004-0527-6

Abstract/Summary

Successful and responsible introduction of probiotic and prebiotic products into the worldwide marketplace requires labelling for health benefits that meets consumer needs, adheres to regulatory standards and does not overextend scientific evidence. Regulations differ among countries, but underlying all is an emphasis on scientific credibility of any statements of health benefits. This paper considers the value of different types of evidence offered in substantiation of efficacy and reviews different regulatory approaches to labelling for health claims. Limitations of in vitro, animal and different types of human studies used for efficacy substantiation for probiotics and prebiotics are discussed.

Altmetric Badge

Item Type Article
URI https://reading-clone.eprints-hosting.org/id/eprint/13015
Item Type Article
Refereed Yes
Divisions Life Sciences > School of Chemistry, Food and Pharmacy > Department of Food and Nutritional Sciences
Uncontrolled Keywords probiotics, prebiotics, regulatory, health claims, PLACEBO-CONTROLLED TRIAL, DIARRHEA
Download/View statistics View download statistics for this item

University Staff: Request a correction | Centaur Editors: Update this record

Search Google Scholar